Polymorphism of NRAMP1 gene in chronic obstructive pulmonary disease patients Source: Eur Respir J 2004; 24: Suppl. 48, 315s Year: 2004
Angiotensin-converting-enzyme gene polymorphism and susceptibility to chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 195s Year: 2002
Polymorphism of the cyclo-oxygenase-2 gene protects against the development of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 439s Year: 2005
Polymorphism of collagen I gene and glutation-S-transferases T1 and M1 in chronic obstructive pulmonary disease associated with cardiovascular disease Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011
Regulation disorders of pulmonary lipid metabolism in chronic obstructive pulmonary disease Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
Polymorphism of glutation-S-transferases T1 and M1 in chronic obstructive pulmonary disease Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011
Polymorphism of the serotonin transporter and 2a receptor gene in COPD with and without pulmonary hypertension Source: Annual Congress 2008 - Pulmonary vascular medicine Year: 2008
Tissue inhibitor of metalloproteinases-;2 gene polymorphisms in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 748-752 Year: 2001
Genetic risks in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003
Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006
Bosentan and pulmonary hypertension in patients affected by chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
Candidate gene associations in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - The biology of smoking and COPD Year: 2008
Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
Effect of phosphodiesterase 5 inhibitor in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021
Erythropoietin dysregulation in chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008
Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002
Effects of severity of chronic obstructive pulmonary disease on thyroid function Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005
Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 226s Year: 2007